Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-10-10
1998-06-02
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514550, 514562, 514603, 514604, A61K 31215, A61K 3119, A61K 3118
Patent
active
057600767
ABSTRACT:
Succinoylamino hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
REFERENCES:
patent: H725 (1990-01-01), Gordon
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4880938 (1989-11-01), Freidinger
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
Rich et al, Peptide Inhibitors of Proteases, 511-520.
Rosenberg et al, J. Med. Chem., 30, 1224-1228 (1987).
Roberts et al, "Rational Design of Peptide-based Proteinase Inhibitors," Science, 248, 358 (1990).
Erickson et al, "Design Activity, and 2.8.ANG. Crystal Structure of a C.sub.2 Symmetric Inhibitor Complexed to HIV-1 Protease," Science, 249, 527 (1990).
Pearl et al, "Sequence specificity of retroviral proteases" Nature, 328, (1987).
Martin, Drug of the Future, 16(3), 210-212 (1991).
Meek et al, Letter To Nature, 343, 90-92 (1990).
McQuade et al, Science, 247, 454-456 (1990).
Darke, et al., "HIV Protease as an inhibitor Target for the Treatment of AIDS", Advances in Pharmacology (25), 399-453, 1994.
DeCrescenzo Gary A.
Freskos John N.
Getman Daniel
Mueller Richard A.
Talley John J.
G.D Searle & Co.
Gerstl Robert
Monsanto Company
LandOfFree
Succinoylamino hydroxyethylamino sulfonamides useful as retrovir does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Succinoylamino hydroxyethylamino sulfonamides useful as retrovir, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Succinoylamino hydroxyethylamino sulfonamides useful as retrovir will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1460309